Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$276M |
| 2 |
Procter & Gamble
PG
|
+$243M |
| 3 |
Analog Devices
ADI
|
+$188M |
| 4 |
Advanced Micro Devices
AMD
|
+$171M |
| 5 |
Home Depot
HD
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$778M |
| 3 |
Walmart Inc
WMT
|
+$723M |
| 4 |
Zoom
ZM
|
+$642M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.3% |
| 2 | Technology | 17.17% |
| 3 | Consumer Staples | 12.21% |
| 4 | Communication Services | 9.94% |
| 5 | Consumer Discretionary | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JCTC
2351
Jewett-Cameron Trading
JCTC
$10.2M
| $1.33M | ﹤0.01% |
172,575
-6,400
| -4% | -$47.1K |
|
|
RUBY
2352
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.33M | ﹤0.01% |
264,728
+109,228
| +70% | +$579K |
|
2353
Brookfield Infrastructure
BIPC
$5.01B
| $1.32M | ﹤0.01% |
35,850
+5,361
| +18% | +$178K |
|
|
ESGR
2354
DELISTED
Enstar Group
ESGR
| $1.32M | ﹤0.01% |
8,200
-18,800
| -70% | -$3.2M |
|
|
GRUB
2355
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $1.32M | ﹤0.01% |
+9,150
| New | +$1.32M |
|
|
STCN
2356
DELISTED
Steel Connect, Inc. Common Stock
STCN
| $1.32M | ﹤0.01% |
261,154
+13,065
| +5% | +$68.5K |
|
2357
UTStarcom
UTSI
$23.2M
| $1.32M | ﹤0.01% |
307,285
+19,286
| +7% | +$115K |
|
2358
LSB Industries
LXU
$731M
| $1.32M | ﹤0.01% |
1,058,273
+252,555
| +31% | +$317K |
|
|
ATYR
2359
aTyr Pharma
ATYR
$54.5M
| $1.32M | ﹤0.01% |
408,430
+42,600
| +12% | +$175K |
|
2360
Semtech
SMTC
$13B
| $1.31M | ﹤0.01% |
24,816
-137,784
| -85% | -$7.74M |
|
2361
Vanguard Morningstar Large-Cap ETF
VV
$54.9B
| $1.31M | ﹤0.01% |
+8,400
| New | +$1.3M |
|
|
CTHR
2362
DELISTED
Charles & Colvard Ltd
CTHR
| $1.31M | ﹤0.01% |
160,191
+43,674
| +37% | +$318K |
|
2363
KT
KT
$9.13B
| $1.31M | ﹤0.01% |
136,400
-31,100
| -19% | -$310K |
|
|
MTA
2364
Metalla Royalty & Streaming
MTA
$917M
| $1.31M | ﹤0.01% |
166,000
+73,700
| +80% | +$570K |
|
|
AT
2365
DELISTED
Atlantic Power Corporation
AT
| $1.31M | ﹤0.01% |
667,701
-298,877
| -31% | -$608K |
|
2366
First United
FUNC
$296M
| $1.31M | ﹤0.01% |
111,720
-9,271
| -8% | -$106K |
|
|
NGM
2367
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $1.31M | ﹤0.01% |
82,200
-86,800
| -51% | -$1.58M |
|
2368
KORU Medical Systems
KRMD
$154M
| $1.3M | ﹤0.01% |
180,700
+10,200
| +6% | +$90.5K |
|
|
SMTX
2369
DELISTED
SMTC Corporation
SMTX
| $1.3M | ﹤0.01% |
360,433
+33,400
| +10% | +$111K |
|
|
JAX
2370
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $1.3M | ﹤0.01% |
249,156
-158,449
| -39% | -$692K |
|
|
MBCN
2371
DELISTED
Middlefield Banc Corp
MBCN
| $1.29M | ﹤0.01% |
67,112
-10,828
| -14% | -$200K |
|
|
FLNA
2372
Filana Therapeutics
FLNA
$44.8M
| $1.29M | ﹤0.01% |
+112,300
| New | +$506K |
|
|
BSCM
2373
DELISTED
Invesco BulletShares 2022 Corporate Bond ETF
BSCM
| $1.29M | ﹤0.01% |
59,068
+30,168
| +104% | +$660K |
|
|
PPIH
2374
Perma-Pipe International
PPIH
$220M
| $1.29M | ﹤0.01% |
227,893
+5,499
| +2% | +$31.7K |
|
|
ISEE
2375
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.29M | ﹤0.01% |
228,180
-893,200
| -80% | -$4.26M |
|
Similar funds
Jim Simons's Q3 2020 Portfolio in Review
As of Q3 2020, Jim Simons held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Microsoft worth $277M.
- Jim Simons's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
- Jim Simons added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
- Jim Simons's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
- Jim Simons fully exited Alibaba in Q3 2020, selling an estimated $426M.
- Jim Simons's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
- Jim Simons opened 490 new positions and closed 544 in Q3 2020.
- Jim Simons's portfolio value fell 14% quarter-over-quarter to $100B.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.